Connect to other sites within the UBM Medica Network
New RA Treatment Strategy: Online Tools for Health Literacy
About half of rheumatoid arthritis patients don't understand enough information to make intelligent treatment choices. Here's how to help.
TNF-α Drugs Don’t Appear to Affect Vaccine Responses in RA
A new meta-analysis shows RA treatments have varied effects on patients’ response to flu and pneumonia vaccines.
How RA Bubbled Up in the Risk-Factor Cauldron of 19th Century Paris
With some historical analysis, a British rheumatologist unearths a persuasive explanation for the emergence of rheumatoid arthritis when and where it did, in fact, arise.
Rheumatoid Arthritis, Aging, and Biologics: Good News
Biologics have added a decade to the lifespan of rheumatoid arthritis patients since only the start of this century. The impact of age on that treatment has been a subject of intense study.
Surveyed RA Patients Value Treatment Convenience Over Safety, Efficacy
An online survey suggests that rheumatoid arthritis (RA) patients want quicker, less frequent treatments even if the trade-offs are adverse reactions or less efficacy.
New Biologics at EULAR 2014: Stop and Wait
(EULAR2014) Which candidate biologics for rheumatology are destined to pass "Go" and collect? A member of the audience at the recent conference presents his observations and comments.
Good Reason to Target Receptor Involved in Synovial Inflammation
Comparison of inflamed and non-inflamed synovium provide support for targeting a receptor for a molecule that stimulates granulocytes in rheumatoid and psoriatic arthritis.